218 related articles for article (PubMed ID: 15821037)
21. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
22. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
23. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.
Clement AB; Hawkins EG; Lichtman AH; Cravatt BF
J Neurosci; 2003 May; 23(9):3916-23. PubMed ID: 12736361
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.
Hegde VL; Hegde S; Cravatt BF; Hofseth LJ; Nagarkatti M; Nagarkatti PS
Mol Pharmacol; 2008 Jul; 74(1):20-33. PubMed ID: 18388242
[TBL] [Abstract][Full Text] [Related]
25. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC
Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552
[TBL] [Abstract][Full Text] [Related]
26. Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary.
Bagavandoss P; Grimshaw S
Anat Rec (Hoboken); 2010 Aug; 293(8):1425-32. PubMed ID: 20665820
[TBL] [Abstract][Full Text] [Related]
27. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
28. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
[TBL] [Abstract][Full Text] [Related]
29. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
31. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
Snider NT; Walker VJ; Hollenberg PF
Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
[TBL] [Abstract][Full Text] [Related]
32. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
Wagner JA; Járai Z; Bátkai S; Kunos G
Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
36. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid CB1 receptors regulate salivation.
Andreis K; Billingsley J; Naimi Shirazi K; Wager-Miller J; Johnson C; Bradshaw H; Straiker A
Sci Rep; 2022 Aug; 12(1):14182. PubMed ID: 35986066
[TBL] [Abstract][Full Text] [Related]
38. Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani S; Cuomo V; Piomelli D
Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824
[TBL] [Abstract][Full Text] [Related]
39. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
Schlosburg JE; Kinsey SG; Lichtman AH
AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
[TBL] [Abstract][Full Text] [Related]
40. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
